SCHEMBL17525486

SCHEMBL17525486

CN1CCN(CCCOCCNCCN2CCOc3cc(N)ccc32)CC1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 5/20 0.40
NOS1 P29475 5/20 0.40
HTR1A P08908 1/20 0.38
SLC6A4 P31645 1/20 0.38
NPY5R Q15761 3/20 0.35
NOS2 P35228 4/20 0.34
KCNH2 Q12809 1/20 0.34
HRH3 Q9Y5N1 2/20 0.33
DRD3 P35462 1/20 0.33
REN P00797 1/20 0.33
NPC1 O15118 2/20 0.32
ALDH1A1 P00352 2/20 0.32
RAB9A P51151 2/20 0.32
ATM Q13315 1/20 0.32
KDM1A O60341 1/20 0.32
KDM4E B2RXH2 2/20 0.32
MAPT P10636 1/20 0.32
RAD52 P43351 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17525505 0.96 NOS3 (0.41) NOS3NOS1HTR1ASLC6A4NPY5R
SCHEMBL17525496 0.90 NOS3 (0.43) NOS3NOS1HTR1ASLC6A4NPY5R
SCHEMBL17859567 0.90 NOS3 (0.37) NOS3NOS1HTR1ASLC6A4NPY5R
SCHEMBL17525487 0.89 NOS3 (0.46) NOS3NOS1HTR1ASLC6A4NPY5R
SCHEMBL17525506 0.88 NOS3 (0.40) NOS3NOS1HTR1ASLC6A4NPY5R
SCHEMBL17525502 0.87 NOS3 (0.39) NOS3NOS1HTR1ASLC6A4NPY5R
SCHEMBL17525492 0.87 NOS3 (0.38) NOS3NOS1HTR1ASLC6A4NOS2
SCHEMBL17859569 0.85 NOS3 (0.38) NOS3NOS1HTR1ASLC6A4NPY5R
SCHEMBL282767 0.83 HTR1A (0.49) NOS3NOS1HTR1ASLC6A4NOS2
SCHEMBL17859635 0.83 NOS3 (0.40) NOS3NOS1HTR1ASLC6A4NPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180141922-A1 BENZOXAZINE DERIVATIVES AND USE IN HAIR DYEING L'OREAL (FR) 2018-05-24 US disclosed
WO-2016020490-A1 BENZOXAZINE DERIVATIVES AND USE IN HAIR DYEING L'OREAL (FR) 2016-02-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180141922-A1 BENZOXAZINE DERIVATIVES AND USE IN HAIR DYEING XDH, KRT18, CYC1 NOS3 602/4885NOS1 1127/4885HTR1A 802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.